Cinclus Pharma Holding AB (OSTO:CINPHA) Buyback Yield % : -147.45 (As of Apr. 26, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Cinclus Pharma Holding AB's current buyback yield was -147.45%.

Cinclus Pharma Holding AB Buyback Yield % Historical Data

The historical data trend for Cinclus Pharma Holding AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Buyback Yield % Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

-71.86

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial					-	-	-49.56	-54.81	-71.86

Competitive Comparison of Cinclus Pharma Holding AB's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Cinclus Pharma Holding AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cinclus Pharma Holding AB's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cinclus Pharma Holding AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Cinclus Pharma Holding AB's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Cinclus Pharma Holding AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Cinclus Pharma Holding AB's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	715)	/	994.98244
	=	-71.86%

Cinclus Pharma Holding AB's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	715)		/	994.98244
	=	-71.86%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Cinclus Pharma Holding AB Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

J8P:Germany

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines